arrow
C

Carmen Balañá

institut investigació germans trias i pujol
H指数:37
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Poor Brain Reserve Increases Mortality Risk in Glioblastoma

胶质母细胞瘤中脑储备不足会增加死亡风险

2026-09-070
OAAI
Unveiling glioblastoma heterogeneity with deep learning derived MRI subtyping: insights from the global ReSPOND consortium

利用深度学习衍生MRI亚型对胶质母细胞瘤异质性进行解析:全球ReSPOND联盟的见解

2025-11-010
OAAI
Self-supervised multimodal learning for survival prediction in glioblastoma: a multicenter study from the ReSPOND consortium

用于胶质母细胞瘤生存预测的自监督多模态学习:来自ReSPOND联盟的多中心研究

2025-11-010
PRE
Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge

通过联合肿瘤分割 (FeTS) 挑战实现医疗AI算法的公平分散基准测试

2025-07-080
OAAI
Early region-specific impact of adjuvant radiation therapy on cognition and quality of life in adult patients with primary brain tumors (Oct, 10.1007/s12094-024-03740-w, 2024)

成人原发性脑肿瘤患者辅助放疗的早期区域性认知与生活质量影响 (Oct, 10.1007/s12094-024-03740-w, 2024)

2025-01-130
PRE
RADIOTHERAPY VERSUS TMZ FOR HIGH-RISK LOW-GRADE GLIOMA. FINAL RESULTS AFTER MEDIAN FOLLOW-UP OF 13 YEARS OF PHASE III EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) STUDY
2024-11-110
PRE
MULTI-INSTITUTIONAL VALIDATION OF AN AI-BASED MODEL FOR PREDICTION OF TUMOR INFILTRATION AND FUTURE RECURRENCE IN PATIENTS WITH GLIOBLASTOMA: RESULTS FROM THE RESPOND CONSORTIUM
2024-11-110
PRE
Progression-free survival 2 (PFS2) as a surrogate for overall survival in a multicentric real-world data cohort of glioblastoma (GBM)

无进展生存期2(PFS2)作为胶质母细胞瘤(GBM)多中心真实世界数据队列中总生存期的替代指标

2024-09-010
PRE
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)
2024-04-171
PRE
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial

Marizomib用于新诊断的胶质母细胞瘤患者: 一项随机3期试验

2024-03-192
OAAI
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma (Dec, 10.1007/s11060-023-04513-1, 2023)

对两项前瞻性随机研究的综合分析,探讨延长放疗后替莫唑胺对新诊断胶质母细胞瘤生存结局的影响 (12月,10.1007/s11060-023-04513-1,2023)

2024-01-301
OA
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma
2023-12-283
PRE